Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  HCA Healthcare, Inc.    HCA

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

HCA Healthcare : 3Q Profit, Revenue Rise

10/26/2020 | 07:08am EST

By Dave Sebastian

HCA Healthcare Inc., one of the nation's largest hospital chains, said its third-quarter profit and sales rose as the company passed the initial months of the coronavirus pandemic and gained experience managing its operations during the crisis.

The Nashville-based company on Monday posted net income of $668 million, or $1.95 a share, for the September quarter compared with $612 million, or $1.76 a share, in the comparable period last year. Analysts polled by FactSet were expecting $2.61 a share. The company earlier this month said it expected income before income taxes of about $950 million.

Revenue rose 4.9% to $13.11 billion from $12.69 billion, in line with the company's expectations. Analysts were looking for $12.9 billion.

The results include a reversal of $822 million, or $1.72 a share, in stimulus income from Coronavirus Aid, Relief, and Economic Security Act funds.

The company earlier this month said it would pay back about $6 billion in federal pandemic relief, the latest indicator of the $1 trillion hospital sector's rebound from the Covid-19 pandemic's effects caused by suspended surgeries and widespread lockdowns. It said it would return the roughly $1.6 billion it received in direct relief from the government and repay its relief loans totaling $4.4 billion ahead of schedule.

For the quarter, HCA said same-facility admissions and equivalent admission fell 3.8% and 9%, respectively. Same-facility emergency-room visits fell 20%. Same-facility inpatient surgeries fell 6.8%, while same-facility outpatient surgeries declined 6.3%. Same-facility revenue per equivalent admission rose 15% due to increase in acuity of patients treated and the payer mix during the quarter, the company said.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

10-26-20 0807ET

All news about HCA HEALTHCARE, INC.
11/03HCA HEALTHCARE : Inc. to Present at November Healthcare Conferences
BU
10/30HCA HEALTHCARE : Latest Covid-19 Wave Worries Hospitals Even With New Treatments
DJ
10/29HCA HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
10/26HCA EXPECTS 4-5% OF TOTAL PATIENT AD : Conf call
RE
10/26HCA Healthcare expects to treat COVID-19 patients throughout 2021
RE
10/26HCA Healthcare expects to treat COVID-19 patients throughout 2021
RE
10/26TENET HEALTHCARE : Amid New Covid-19 Surge, Hospitals Balance Virus Care With Mo..
DJ
10/26HCA HEALTHCARE, INC. : Results of Operations and Financial Condition, Regulation..
AQ
10/26HCA HEALTHCARE : 3Q Profit, Revenue Rise
DJ
10/26HCA HEALTHCARE :  HCA Healthcare Reports Third Quarter 2020 Results
BU
More news
Financials (USD)
Sales 2020 51 190 M - -
Net income 2020 3 729 M - -
Net Debt 2020 30 246 M - -
P/E ratio 2020 14,4x
Yield 2020 0,28%
Capitalization 51 788 M 51 788 M -
EV / Sales 2020 1,60x
EV / Sales 2021 1,51x
Nbr of Employees 245 000
Free-Float 78,3%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 154,23 $
Last Close Price 153,05 $
Spread / Highest target 16,3%
Spread / Average Target 0,77%
Spread / Lowest Target -11,8%
EPS Revisions
Managers
NameTitle
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
Thomas Fearn Frist Chairman
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Jonathan B. Perlin Chief Medical Officer & President-Clinical Service
P. Martin Paslick Chief Information Officer & Senior Vice President
Sector and Competitors